Azithromycin for Meibomian Gland Disease

NCT03953118 PHASE4 TERMINATED Results posted

This study aims to elucidate the effectiveness of oral azithromycin in treating symptomatic dry eye syndrome secondary to Meibomian gland dysfunction.

Details

Lead sponsor	University of California, San Francisco
Phase	PHASE4
Status	TERMINATED
Enrolment	2
Start date	Sun Sep 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Thu Jul 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Dry Eye
• Neuropathic Eye Pain
• Ocular Microbiome
• Depression, Anxiety

Interventions

• Azithromycin Oral Product
• Placebo Oral

Countries

United States